Standout Papers
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1998)
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1998)
Citation Impact
Citing Papers
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Intracranial hemorrhage in newborn and young infants with hemophilia
1988
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Inflammation and cancer
2002 StandoutNature
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
2005
Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders
2003
Bone marrow transplantation for sickle cell anemia: Progress and prospects
2004
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Acute graft-vs-host disease
2001
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The Transplantation of Hematopoietic Stem Cells After Non-Myeloablative Conditioning: A Cellular Therapeutic Approach to Hematologic and Genetic Diseases
2003
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Multiple myeloma
2000 Standout
The role of imidazoline receptors in blood pressure regulation
1992
Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
2007
Angiogenesis in health and disease
2003 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis
1990
Nonaccidental Head Injury in Infants — The “Shaken-Baby Syndrome”
1998 Standout
Graft-versus-host disease
2009 Standout
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
2003
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
2006
Stroke in Children With Sickle Cell Anaemia
2001
Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy
2008
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISM
1999
Bone marrow transplantation in sickle cell anemia
2001
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Myocardial Reperfusion Injury
2007 Standout
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
1999
Protective Conditioning for Acute Graft-versus-Host Disease
2005
Idarucizumab for Dabigatran Reversal
2015 Standout
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells
2003
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Modulation of Leukocyte Behavior by an InflamedExtracellular Matrix
2000
Cancer-related inflammation
2008 StandoutNature
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Contact between a polymer and whole blood: Sequence of events leading to thrombin generation
2001
Mixed chimerism and immunosuppressive drug withdrawal after hla-mismatched kidney and hematopoietic progenitor transplantation1
2002
Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation
2009
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
2004
French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)
2010
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
2000 Standout
Engraftment syndrome following hematopoietic stem cell transplantation
2001
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study
2002
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype
2007
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Mini-allografts: ongoing trials in humans
2000
A Functional Proteomics Screen of Proteases In Colorectal Carcinoma
2000
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
2004
Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management
1997
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
2001
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
2003
Cell Surface Antigen and Molecular Targeting in the Treatment of Hematologic Malignancies
2002
Stromal-derived factor 1–induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases
2000
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c
1996 StandoutScienceNobel
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
2008
Transendothelial Migration of Megakaryocytes in Response to Stromal Cell-derived Factor 1 (SDF-1) Enhances Platelet Formation
1998
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
2003
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Magnesium and lipids in cardiovascular disease.
1986
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
2004
Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells
2002
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning
2003
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
2004
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Multiple Myeloma
2011 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy
2003
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
2002
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
2003
Works of A Eldor being referenced
Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation
2004
Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: Further evidence for smoldering inflammation in patients with atherosclerosis
1999
Disseminated Visceral Fusariosis Treated with Amphotericin B-Phospholipid Complex
1993
A low molecular weight brain substance interacts, similarly to clonidine, with α2-adrenoceptors of human platelets
1987
Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix
1990
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites
1991
Abnormal Platelet Functions in β Thalassaemia
1978
Circulating megakaryocytes and platelet production in the lungs.
1990
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Intracranial Hemorrhage in Patients with Hemophilia
1986
Effect of magnesium sulfate on platelet deposition in rabbits following temporary arterial occlusion with surgical clips.
1980
Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia
1996
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Adhesion, spreading and fragmentation of human megakaryocytes exposed to subendothelial extracellular matrix: a scanning electron microscopy study.
1986